Li, D., Mielke, M. M., Bell, W. R., Reilly, C., Zhang, L., Lin, F. V., & Yu, F. (2020). Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: The blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Trials.
Chicago Style citaatLi, Danni, Michelle M. Mielke, W. Robert Bell, Cavan Reilly, Lin Zhang, Feng Vankee Lin, en Fang Yu. "Blood Biomarkers As Surrogate Endpoints of Treatment Responses to Aerobic Exercise and Cognitive Training (ACT) in Amnestic Mild Cognitive Impairment: The Blood Biomarkers Study Protocol of a Randomized Controlled Trial (the ACT Trial)." Trials 2020.
MLA citatieLi, Danni, et al. "Blood Biomarkers As Surrogate Endpoints of Treatment Responses to Aerobic Exercise and Cognitive Training (ACT) in Amnestic Mild Cognitive Impairment: The Blood Biomarkers Study Protocol of a Randomized Controlled Trial (the ACT Trial)." Trials 2020.